382 related articles for article (PubMed ID: 20661085)
41. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
[TBL] [Abstract][Full Text] [Related]
42. TGF-β1 protein expression in non-small cell lung cancers is correlated with prognosis.
Huang AL; Liu SG; Qi WJ; Zhao YF; Li YM; Lei B; Sheng WJ; Shen H
Asian Pac J Cancer Prev; 2014; 15(19):8143-7. PubMed ID: 25338997
[TBL] [Abstract][Full Text] [Related]
43. ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
Booton R; Ward T; Ashcroft L; Morris J; Heighway J; Thatcher N
J Thorac Oncol; 2007 Oct; 2(10):902-6. PubMed ID: 17909351
[TBL] [Abstract][Full Text] [Related]
44. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
45. Down-regulation of MTA1 protein leads to the inhibition of migration, invasion, and angiogenesis of non-small-cell lung cancer cell line.
Li S; Tian H; Yue W; Li L; Gao C; Si L; Li W; Hu W; Qi L; Lu M
Acta Biochim Biophys Sin (Shanghai); 2013 Feb; 45(2):115-22. PubMed ID: 23343746
[TBL] [Abstract][Full Text] [Related]
46. Co-overexpression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 adversely affects the postoperative survival in non-small cell lung cancer.
Wu YC; Su LJ; Wang HW; Jeff Lin CF; Hsu WH; Chou TY; Huang CY; Lu CL; Hsueh CT
J Thorac Oncol; 2010 Aug; 5(8):1167-74. PubMed ID: 20592629
[TBL] [Abstract][Full Text] [Related]
47. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
[TBL] [Abstract][Full Text] [Related]
48. The clinical value of lymphatic micrometastases in patients with non-small cell lung cancer.
Verhagen AF; Bulten J; Shirango H; Thunnissen FB; van der Drift MA; van der Bruggen W; Tjan-Heijnen VC; van Swieten HA
J Thorac Oncol; 2010 Aug; 5(8):1201-5. PubMed ID: 20588201
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer.
Han KY; Gu X; Wang HR; Liu D; Lv FZ; Li JN
Tumour Biol; 2013 Apr; 34(2):821-5. PubMed ID: 23229099
[TBL] [Abstract][Full Text] [Related]
50. FBXO25 promotes cell proliferation, invasion, and migration of NSCLC.
Jiang GY; Zhang XP; Wang L; Lin XY; Yu JH; Wang EH; Zhang Y
Tumour Biol; 2016 Oct; 37(10):14311-14319. PubMed ID: 27596142
[TBL] [Abstract][Full Text] [Related]
51. CCDC85B promotes non-small cell lung cancer cell proliferation and invasion.
Feng Y; Gao Y; Yu J; Jiang G; Zhang X; Lin X; Han Q; Rong X; Xu H; Li Q; Qiu X; Wang E
Mol Carcinog; 2019 Jan; 58(1):126-134. PubMed ID: 30242906
[TBL] [Abstract][Full Text] [Related]
52. WT1 promotes invasion of NSCLC via suppression of CDH1.
Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y
J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386
[TBL] [Abstract][Full Text] [Related]
53. Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues.
Boukakis G; Patrinou-Georgoula M; Lekarakou M; Valavanis C; Guialis A
BMC Cancer; 2010 Aug; 10():434. PubMed ID: 20716340
[TBL] [Abstract][Full Text] [Related]
54. CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer.
Otsuka S; Klimowicz AC; Kopciuk K; Petrillo SK; Konno M; Hao D; Muzik H; Stolte E; Boland W; Morris D; Magliocco AM; Bebb DG
J Thorac Oncol; 2011 Jul; 6(7):1169-78. PubMed ID: 21623238
[TBL] [Abstract][Full Text] [Related]
55. The relationship between RGS5 expression and cancer differentiation and metastasis in non-small cell lung cancer.
Huang G; Song H; Wang R; Han X; Chen L
J Surg Oncol; 2012 Mar; 105(4):420-4. PubMed ID: 21780128
[TBL] [Abstract][Full Text] [Related]
56. miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion.
Zhang H; Zhu X; Li N; Li D; Sha Z; Zheng X; Wang H
Acta Biochim Biophys Sin (Shanghai); 2015 Jul; 47(7):496-503. PubMed ID: 25998575
[TBL] [Abstract][Full Text] [Related]
57. Expression of tumor necrosis factor receptor-associated factor 6 in lung cancer tissues.
Zhang XL; Dang YW; Li P; Rong MH; Hou XX; Luo DZ; Chen G
Asian Pac J Cancer Prev; 2014; 15(24):10591-6. PubMed ID: 25605144
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
59. Correlation between metastasis-associated gene 1 expression and tumor-associated macrophages in non-small cell lung cancer.
Ma K; Li YX; Guo QQ
Neoplasma; 2022 Sep; 69(5):1092-1100. PubMed ID: 35951452
[TBL] [Abstract][Full Text] [Related]
60. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
